5-Bromo-2’-deoxyuridineisasyntheticnucleosideanalogofthymidinethatisusedinresearchmodelstolabelactivelyproliferatingcells.ThiscompoundisincorporatedintoDNAbutatlowlevelsdoesnotalterDNAreplication.Athighlevels,thiscompounddisplaysimmunosuppressiveactivityandhasshownsomeanticancerbenefitwhenusedasachemotherapyrADIosensitizer.
| CasNo. | 59-14-3 |
|---|---|
| Purity | ≥98% |
| Formula | C9H11BrN2O5 |
| FormulaWt. | 307.11 |
| ChemicalName | 5-Bromo-2"-deoxyuridine |
| IUPACName | 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
| Synonym | Broxuridine;5-bromouracildeoxyriboside;BUdR;Broxine;Neomark;Radibud |
| MeltingPoint | 187-189°C |
| Solubility | Solubleindimethyl-acetamide,1NNaOH,ordimethylsulfoxide.Slightlysolubleinwater. |
| Appearance | Whitecrystallinepowder |
| StoreTemp | -20°C |
|---|---|
| ShipTemp | Ambient |
| MSDS | B6856MSDSPDF |
|---|---|
| InfoSheet | B6856InfoSheetPDF |
ZhangR,ZhangJ,FangL,etal.NeuroprotectiveeffectsofsulforaphaneoncholinergicneuronsinmicewithAlzheimer"sdisease-likelesions.IntJMolSci.2014Aug18;15(8):14396-410.PMID:25196440.
JeongCH,KimSM,LimJY,etal.Mesenchymalstemcellsexpressingbrain-derivedneurotrophicfactorenhanceendogenousneurogenesisinanischemicstrokemodel.BiomedResInt.2014;2014:129145.PMID:24672780.
RussoA,GianniL,KinsellaTJ,etal.Pharmacologicalevaluationofintravenousdeliveryof5-bromodeoxyuridinetopatientswithbraintumors.CancerRes.1984Apr;44(4):1702-5.PMID:6704976.
